We have expanded the list of climate policies we assess company engagement with to incorporate land-use related policy, referring to legislative or regulatory measures to enhance and protect ecosystems and land where carbon is being stored. Assessments under this category are currently underweighted in terms of their contribution to the overall company metrics. This weighting will be progressively increased over the next 6 months.
We adjusted the terminology used to describe the queries running down the left-hand side of our scoring matrix and added additional explanatory text to the info-boxes. This has no impact on the scores and methodology. It has been done following user feedback to improve clarity.
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the NAM on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Mike McDermott President, Pfizer Global Supply is an Executive Committee Member
Mike McDermott President, Pfizer Global Supply
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer stated in its 2019 CDP response that its position on climate change is of mixed consistency with NAM's, however, Pfizer has not provided any evidence of areas of misalignment with NAM.
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior Executive of Pfizer is Executive Committee Member of NAM
Mike McDermott
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior Executive of Pfizer is Executive Committee Member of NAM
Kirsten Lund-Jurgensen
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the NAM on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Mike McDermott President, Pfizer Global Supply is an Executive Committee Member
Mike McDermott President, Pfizer Global Supply
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer stated in its 2019 CDP response that its position on climate change is of mixed consistency with NAM's, however, Pfizer has not provided any evidence of areas of misalignment with NAM.
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior Executive of Pfizer is Executive Committee Member of NAM
Mike McDermott
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior Executive of Pfizer is Executive Committee Member of NAM
Kirsten Lund-Jurgensen
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
President of Pfizer Canada is Co-Chair of Canadian Chamber of Commerce COVID-19 Recovery Leadership Council
Cole Pinnow, President of Pfizer Canada
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a member of the Canadian Chamber of Commerce
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
President of Pfizer Canada is Co-Chair of Canadian Chamber of Commerce COVID-19 Recovery Leadership Council
Cole Pinnow, President of Pfizer Canada
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a member of the Canadian Chamber of Commerce
InfluenceMap Data Point on Corporate - Influencer Relationship
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the Chamber on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer executive Jennifer Walton is a member of the Chamber's Board of Directors. Pfizer is also a founding member of the Climate Solutions Working Group, according to CDP 2020 disclosure.
Jennifer Walton, Head of Office and Vice President, Government Relations
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer executive Robert Jones is a member of the Chamber's Board of Directors.
Robert Jones, Senior Vice President, Government Affairs
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer has stated in their CDP their position on climate change is of mixed consistency with US Chamber of Commerce and state they were influential in the US Chamber's latest climate policy statement. However, they do not provide an example of an area where they are currently misaligned from the US Chamber
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-Japan Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-Turkey Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
member of Brazil-US Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-UK Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Senior Executive of Pfizer is on the Board of Directors of USCC
Ken Cole
InfluenceMap Data Point on Corporate - Influencer Relationship
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the Chamber on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer executive Jennifer Walton is a member of the Chamber's Board of Directors. Pfizer is also a founding member of the Climate Solutions Working Group, according to CDP 2020 disclosure.
Jennifer Walton, Head of Office and Vice President, Government Relations
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer executive Robert Jones is a member of the Chamber's Board of Directors.
Robert Jones, Senior Vice President, Government Affairs
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer has stated in their CDP their position on climate change is of mixed consistency with US Chamber of Commerce and state they were influential in the US Chamber's latest climate policy statement. However, they do not provide an example of an area where they are currently misaligned from the US Chamber
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-Japan Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-Turkey Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
member of Brazil-US Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a member of the US-UK Business Council
InfluenceMap Data Point on Corporate - Influencer Relationship
Senior Executive of Pfizer is on the Board of Directors of USCC
Ken Cole
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer is a partner company in the Corporate Advisory and Support Group
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chapter of the ICC, called the USCIB
Jonathan Selib, Senior Vice President, Global Policy and International Public Affairs Pfizer
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chpater of the ICC
Jonathan Selib
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chpater of the ICC
Justin McCarthy
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chapter of the ICC, called the USCIB
Jonathan Selib, Senior Vice President, Global Policy and International Public Affairs Pfizer
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chpater of the ICC
Jonathan Selib
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Senior executive of Pfizer is a board member of the US Chpater of the ICC
Justin McCarthy
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a corporate member of Keidanren
not specified
--no extract--
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a corporate member of Keidanren
not specified
--no extract--
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Business Member (ABM) of CEFIC (as of October 2022)
not specified
--no extract--
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Business Member of CEFIC
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Direct Business Member of Cefic
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Business Member (ABM) of CEFIC (as of October 2022)
not specified
--no extract--
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Business Member of CEFIC
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a Direct Business Member of Cefic
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the Business Roundtable on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer Chairman Albert Bourla is a member of Business Roundtable
Albert Bourla Chairman and Chief Executive Officer Pfizer Inc.
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer stated in its 2019 CDP response that its position on climate change is of mixed consistency with Business Roundtable's, however, Pfizer has not provided any evidence of areas of misalignment with Business Roundtable
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer CEO is a Direct Member
Albert Bourla
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer CEO is a Direct Member
Ian C. Read
InfluenceMap Data Point on Corporate - Influencer Relationship
In it's 2021 Industry Association report, Pfizer has stated that it is well aligned with the Business Roundtable on broad policy goals. (Pfizer Industry Association Report on Incongruencies, December 2021)
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer Chairman Albert Bourla is a member of Business Roundtable
Albert Bourla Chairman and Chief Executive Officer Pfizer Inc.
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer stated in its 2019 CDP response that its position on climate change is of mixed consistency with Business Roundtable's, however, Pfizer has not provided any evidence of areas of misalignment with Business Roundtable
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer CEO is a Direct Member
Albert Bourla
InfluenceMap Data Point on Corporate - Influencer Relationship
Pfizer CEO is a Direct Member
Ian C. Read
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is one of over 100 full members of the Australian Chamber of Commerce and Industry
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is one of over 100 full members of the Australian Chamber of Commerce and Industry
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is one of over 100 full members of the Australian Chamber of Commerce and Industry
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is one of over 100 full members of the Australian Chamber of Commerce and Industry
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Deutschland GmbH is a member of VCI (Up to date as of April 2022)
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a member of VCI
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
subsidiaries of Pfizer are members of VCI
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Deutschland GmbH is a member of VCI (Up to date as of April 2022)
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer is a member of VCI
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
subsidiaries of Pfizer are members of VCI
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Limited is a member of CBI President's Committee
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Limited is a member of CBI President's Committee
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Limited is a member of CBI President's Committee
not specified
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer Limited is a member of CBI President's Committee
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer may be a member of the Florida Chamber of Commerce. Listed as a Silver Sponsor at the 2022 Florida Chamber Annual Meeting & Future of Florida Forum, but unclear if Pfizer is an annual dues-paying member of the group (Florida Chamber, Facebook, October 2022)
InfluenceMap Data Point on Corporate - Influencer Relationship
(1 = weak, 10 = strong)
Pfizer may be a member of the Florida Chamber of Commerce. Listed as a Silver Sponsor at the 2022 Florida Chamber Annual Meeting & Future of Florida Forum, but unclear if Pfizer is an annual dues-paying member of the group (Florida Chamber, Facebook, October 2022)
In this section, we depict graphically the relationships the corporation has with trade associations, federations, advocacy groups and other third parties who may be acting on their behalf to influence climate change policy. Each of the columns above represents one relationship the corporation appears to have with such a third party. In these columns, the top, dark section represents the strength of the relationship the corporation has with the influencer. For example if a corporation's senior executive also held a key role in the trade association, we would deem this to be a strong relationship and it would be on the far left of the chart above, with the weaker ones to the right. Click on these grey shaded upper sections for details of these relationships. The middle section contains a link to the organization score details of the influencer concerned, so you can see the details of its climate change policy influence. Click on the middle sections for for details of the trade associations. The lower section contains the organization score of that influencer, the lower the more negatively it is influencing climate policy.
Open PDF file of Data Source
Climate Lobbying Overview: Pfizer’s top line positions on climate policy appear broadly positive, but the company demonstrates limited engagement with specific climate-related policy. Pfizer broadly supports measures like clean energy, energy efficiency and zero-emissions vehicles. However, it retains memberships to industry associations which have lobbied in strong opposition to climate policy, such as the US Chamber of Commerce, National Association of Manufacturers, and Business Europe.
Top-line Messaging on Climate Policy: Pfizer’s top-line messaging on climate policy appears largely positive. In April 2021, it signed the We Mean Business Coalition’s open letter to President Biden supporting net-zero emissions by 2050 and calling on the United States to adopt an ambitious 2030 NDC target. In its corporate Climate Change Position Statement in March 2021, Pfizer communicated broad support for governmental policy frameworks that include alignment of policy goals and GHG emissions reduction targets with current scientific evidence and IPCC-based consensus recommendations. Pfizer reiterated its position on the science of climate change and the need for drastic action news report released on the companies' website.
Engagement with Climate-Related Regulations: Pfizer appears to have limited engagement with specific climate-related regulation. In March 2023, Pfizer signed a joint letter advocating for EU states to adopt a stringent EU zero-emissions 2035 CO2 target for cars and vans without an e-fuels loophole. The company’s March 2021 Climate Change Position Statement appears to generally welcome climate-related regulations, particularly ones that establish a price on carbon. At the same time, it is unclear if Pfizer prefers government policy or voluntary market-based measures to achieve this. Pfizer has not engaged on climate related policies in the Build Back Better Act.
Positioning on Energy Transition: Pfizer’s positions on the energy transition are positive, though supported by limited engagement. The open letter to the United States President Biden signed by Pfizer in April 2021 communicated broad support for the transition of the energy mix, including clean energy, energy efficiency, zero-emissions vehicles, and durable carbon removal. Pfizer’s corporate statement updated on March 2021 shows general support for policy frameworks that promote energy efficiency, renewable energy, and emissions reduction technologies.
Industry Association Governance: Pfizer provides some disclosure of its trade association memberships on its corporate website and detailed some of its memberships in trade associations in its 2020 CDP report, with details of its alignment with the climate positions of those groups. The company is a member of multiple trade associations obstructing climate change policy. For example, Pfizer’s senior executive is on the board of the US Chamber of Commerce. In 2017, the company helped establish the Climate Solutions Working Group (CSWG), a standalone group of Chamber members that collaborate to advance business interests in climate change solutions and engage within the Chamber on climate change issues. Furthermore, Pfizer’s President of Global Supply is an executive committee member at the National Association of Manufacturers (NAM). NAM has consistently opposed ambitious climate policy in the US.